Avalon, GSK fund two more startups under collaboration

Avalon Ventures and GlaxoSmithKline have launched Silarus Therapeutics and Thyritope Biosciences, the second and third San Diego-based biotechnology companies formed under a partnership that Avalon and GSK initiated in 2013 to fund up to 10 new startup firms.

More from Alimentary/Metabolic

More from Therapy Areas